Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the immunotherapy has ceased, according to data presented at ACR 2019 in Atlanta, Georgia.
The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work. I was not really surprised by reading that, and I would go as far as saying that our
At the 2019 ACR Annual Meeting in Atlanta, almost 500 presentations discussed new randomized controlled trials (RCTs). We are lucky to have so much research activity in our field, but applying an RCT to your daily practice can be challenging. Here are three tips to supercharge your critical
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.
It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting.
I attended my first ACR Annual Meeting in 2011 in Chicago. In that meeting, there were 29 abstracts on autoinflammatory diseases and there were no sessions exclusively focusing on that topic*.
“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.
As a rheumatologist, I pride myself on being an advocate for my patients, but I'm not always an advocate for my profession or myself. Should rheumatologists be involved in policy? Should we be political?
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades. Despite our best effort, there is still significant amount of patients who remain symptomatic and/or experiences progressive joint damage and
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one.
Delays in Diagnosis
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases attempting pregnancy.
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.
The annual ACR/ARP meeting will begin today, Sunday. For many this is the premier meeting in rheumatology. For the ACR it is their biggest educational event. It's also big for industry, academics, North American and international rheumatologists and especially important to those who will be
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
One area I am very interested to learn more about at #ACR19 are the rheumatic manifestations of cancer immunotherapies. In the last 5 years, there has been an expansion of the use of immune checkpoint inhibitor (CPIs) therapy in cancer. The number of patients treated with CPIs is predicted to
I have been attending the ACR Review Course for more than a decade, and it seems every year it gets better and better. Contrary to what most people think, this is not a board review course; it is more of a review of the latest research delivered by experts condensing rheumatology in eight hours.
I’m excited to participate as a RheumNow reporter at this year’s ACR. As we head into the conference, I reflect on the role Twitter will have this week and on a larger scale, the role of social media in medicine.
Like many rheumatologists who are headed to the 2019 American College of Rheumatology meeting in Atlanta, I am eagerly looking forward to learning about the new criteria in vasculitis, lupus, and autoinflammatory recurrent fevers. Yet conference attendees should remember that these criteria are